MCID: INT394
MIFTS: 21

Intermittent Asthma

Categories: Respiratory diseases

Aliases & Classifications for Intermittent Asthma

MalaCards integrated aliases for Intermittent Asthma:

Name: Intermittent Asthma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0080812

Summaries for Intermittent Asthma

Disease Ontology : 12 A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control two or fewer days per week and no interference with normal activity.

MalaCards based summary : Intermittent Asthma is related to asthma and allergic rhinitis. An important gene associated with Intermittent Asthma is ADORA2A (Adenosine A2a Receptor). The drugs Fluticasone and Budesonide have been mentioned in the context of this disorder. Affiliated tissues include neutrophil, lung and skin.

Related Diseases for Intermittent Asthma

Diseases related to Intermittent Asthma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 10, show less)
# Related Disease Score Top Affiliating Genes
1 asthma 29.9 RNASE3 ADORA2A
2 allergic rhinitis 10.0
3 rhinitis 10.0
4 bronchitis 10.0
5 respiratory allergy 9.8
6 exercise-induced bronchoconstriction 9.8
7 allergic asthma 9.8
8 hypereosinophilic syndrome 9.8
9 plastic bronchitis 9.8
10 malaria 9.5 RNASE3 ADORA2A

Graphical network of the top 20 diseases related to Intermittent Asthma:



Diseases related to Intermittent Asthma

Symptoms & Phenotypes for Intermittent Asthma

Drugs & Therapeutics for Intermittent Asthma

Drugs for Intermittent Asthma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 42, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
2
Budesonide Approved Phase 4 51333-22-3 63006 5281004
3 Anti-Asthmatic Agents Phase 4
4 Respiratory System Agents Phase 4
5 Hormones Phase 4
6 Hormone Antagonists Phase 4
7 glucocorticoids Phase 4
8 Dermatologic Agents Phase 4
9 Bronchodilator Agents Phase 4
10 Anti-Inflammatory Agents Phase 4
11 Anti-Allergic Agents Phase 4
12
mometasone furoate Approved, Investigational, Vet_approved Phase 3 83919-23-7
13
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
14
Desloratadine Approved, Investigational Phase 3 100643-71-8 124087
15
Glutaral Experimental Phase 3 111-30-8 3485
16 Neurotransmitter Agents Phase 3
17 Cholinergic Agents Phase 3
18
Histamine Phosphate Phase 3 51-74-1 65513
19 Histamine H1 Antagonists, Non-Sedating Phase 3
20 Histamine H1 Antagonists Phase 3
21 Cholinergic Antagonists Phase 3
22 Histamine Antagonists Phase 3
23
Aluminum hydroxide Approved, Investigational Phase 2 21645-51-2
24
Terbutaline Approved Phase 2 23031-25-6 5403
25
Olodaterol Approved Phase 2 868049-49-4
26 Gastrointestinal Agents Phase 2
27 Adjuvants, Immunologic Phase 2
28 Immunologic Factors Phase 2
29 Antacids Phase 2
30 Anti-Ulcer Agents Phase 2
31 Adrenergic beta-Agonists Phase 2
32 Adrenergic Agonists Phase 2
33 Sympathomimetics Phase 2
34 Adrenergic Agents Phase 2
35 Formoterol Fumarate Phase 2
36 Tocolytic Agents Phase 2
37
Salmeterol xinafoate Phase 2 94749-08-3 56801
38 Fluticasone-Salmeterol Drug Combination Phase 2
39 Pharmaceutical Solutions Phase 2
40 Vaccines Phase 2
41 Albuterol Phase 1
42 Pulmonary Surfactants

Interventional clinical trials:

(showing 15, show less)
# Name Status NCT ID Phase Drugs
1 Does a Lipophilic Steroid Inhaled After an Early Allergic Reaction Affect the Late Reaction? Completed NCT00716963 Phase 4 Fluticasone propionate (Flovent Diskus) 250 mcg;budesonide 400 mcg
2 Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma Completed NCT01694836 Phase 3
3 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Intraseasonal Specific Short-term Immunotherapy With Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depiquick® Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma Completed NCT01902992 Phase 3 Depiquick Birch (DPG103);Placebo
4 An Exploratory Study of Mometasone Furoate Nasal Spray in Patients With Moderate-severe Persistent Allergic Rhinitis and Intermittent Asthma: Effects on the Quality of Life Evaluated With the Rhinasthma Questionnaire Completed NCT00599027 Phase 3 Mometasone furoate nasal spray (MFNS);Placebo nasal spray
5 Evaluation of the Efficacy and Safety of Desloratadine Syrup in Children Suffering From Seasonal Allergic Rhinitis With or Without Intermittent Asthma Completed NCT00805324 Phase 3 Desloratadine
6 A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma Completed NCT01634958 Phase 2
7 A Randomised, Double Blind, Placebo Controlled, Parallel-group Study With Use of Budesonide/Formoterol "As-needed", or Terbutaline "As-needed" or Regular Use of Budesonide + Terbutaline "As-needed", in Patients With Mild Intermittent Asthma Completed NCT00989833 Phase 2 budesonide;terbutaline;budesonide/formoterol
8 A Randomised, Open Label, Five-way Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol From SERETIDE/ADVAIR 250HFA MDI Alone and With AeroChamber-Max Spacer and VOLUMATIC Both in Their Washed and Unwashed States in Adult Subjects With Mild or Intermittent Asthma Completed NCT00369993 Phase 2 fluticasone propionate/salmeterol
9 Randomized, DB, Parallel Group, MC Study to Evaluate the Efficacy and Safety of Four Doses of Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depigoid Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma Completed NCT01144429 Phase 2
10 Randomised, Double-Blind, Placebo-Controlled, 5-Way Cross-Over Study to Assess the Efficacy (Bronchoprotection) and Safety of a Single Dose of Orally Inhaled BI 1744 CL (2, 5, 10 and 20ug) in Patients With Intermittent Asthma Completed NCT00928668 Phase 2 Placebo;Olodaterol (BI1744CL);Olodaterol (BI1744CL);Olodaterol (BI1744CL);Olodaterol (BI1744CL)
11 A Randomized, Double-Blind, Chronic-Dosing (14 Days), 5-Period, 7-Treatment, Placebo-Controlled, Incomplete Block, Cross-Over, Multicenter, Dose-ranging Study to Assess the Efficacy and Safety of PT001 Relative to Placebo Metered Dose Inhaler and Open-Label Serevent® Diskus® in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma Completed NCT02433834 Phase 2 Glycopyrronium MDI;Serevent Diskus 50 μg;Placebo
12 Clinical Exploring Study of Weiyang Yuping Decoction in Preventing Acute Attacks of Mild to Moderate Intermittent Asthma Based on the Theory of "Preventing Disease From Exacerbating" in Chinese Medicine Not yet recruiting NCT04522726 Phase 2 Weiyang Yuping Fang
13 Prospective Study to Evaluate the Safety of a 4-month Treatment With Depigoid® Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml) in Patients With Allergic Rhinitis or Rhinoconjunctivitis With or Without Mild Persistent or Intermittent Asthma Terminated NCT01591343 Phase 2
14 A Stepwise, Rising Dose Study of Male Subjects With Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI Compared With Placebo Acu-30™ DPI Completed NCT00565591 Phase 1 Albuterol sulfate
15 Ex Vivo Effect of Fragments and Modified Forms of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging Completed NCT01378624

Search NIH Clinical Center for Intermittent Asthma

Genetic Tests for Intermittent Asthma

Anatomical Context for Intermittent Asthma

MalaCards organs/tissues related to Intermittent Asthma:

40
Neutrophil, Lung, Skin, Spleen, Smooth Muscle, Kidney, Thyroid

Publications for Intermittent Asthma

Articles related to Intermittent Asthma:

(showing 354, show less)
# Title Authors PMID Year
1
Mental Well-being and General Health in Adolescents with Asthma: The Prevention and Incidence of Asthma and Mite Allergy Birth Cohort Study. 61
33548259 2021
2
Inhaled corticosteroids use in childhood respiratory diseases: an italian survey on pediatricians' prescription habits. 61
33588923 2021
3
Ineffective CPAP Treatment After Effective CPAP Titration. 61
33280775 2020
4
Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program. 61
33270095 2020
5
The Impact of Food Histamine Intake on Asthma Activity: A Pilot Study. 61
33167542 2020
6
Sublingual immunotherapy for asthma. 61
32926419 2020
7
E-cigarette or Vaping Product Use-Associated Lung Injury Presenting as Sub-Acute Hypoxemia Without Increased Work of Breathing. 61
32963897 2020
8
Identifying Psychological Difficulties in College Athletes. 61
32209401 2020
9
Prevalence of asthma at a school-based health clinic in Nicaragua. 61
32040249 2020
10
Cardiac autonomic modulation assessed by heart rate variability in children with asthma. 61
32119199 2020
11
Determinants of severe exercise-induced bronchoconstriction in Nigerian children with asthma. 61
31990143 2020
12
Assessment of The Role of Serum Neutrophil Gelatinase-Associated Lipocalin in Egyptian Childhood Bronchial Asthma: One Centre Study. 61
33548981 2020
13
Validation of the breathmobile case identification survey for asthma screening in children with sickle cell disease. 61
32160791 2020
14
Persistent Asthma Is Associated With Increased Risk for Incident Atrial Fibrillation in the MESA. 61
32013555 2020
15
Documentation of asthma control and severity in pediatrics: analysis of national office-based visits. 61
30657001 2020
16
Asthma co-morbidities in Nigerian children: prevalence, risk factors and association with disease severity and symptoms control. 61
32636989 2020
17
Assessment of Asthma Control and Quality of Life among Asthmatic Patients Attending Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia. 61
32802503 2020
18
Thyrotoxic periodic paralysis presenting in an African-American teenage male: case report. 61
32346386 2020
19
An online survey detected knowledge gaps and cost-saving opportunities in asthma maintenance treatment among allergists, pulmonologists, ENTs and primary care. 61
31768217 2019
20
Lessons learned from clinical trials of asthma. 61
31690382 2019
21
[A neglected bronchial foreign body for 23 years]. 61
31521433 2019
22
Monitoring of respiratory resistance in the diagnosis of mild intermittent asthma. 61
30801802 2019
23
Short-course administration of a traditional herbal mixture ameliorates asthma symptoms of the common cold in children. 61
30984577 2019
24
A 31-Year-Old Man With Airflow Obstruction, Intrathoracic Adenopathy, and Pulmonary Nodules. 61
30732704 2019
25
Diagnosis and Treatment of Asthma in Nonpregnant Women. 61
30484945 2019
26
Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China. 61
30691461 2019
27
Simultaneous Bilateral Primary Spontaneous Pneumothorax: A Case Report and a Review of the Literature. 61
30809412 2019
28
Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor. 61
29518425 2018
29
The effect of balance training intervention on postural stability in children with asthma. 61
28699850 2018
30
Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. 61
28944531 2018
31
Asthma exacerbations: risk factors for hospital readmissions. 61
28593573 2018
32
Four Months of a School-Based Exercise Program Improved Aerobic Fitness and Clinical Outcomes in a Low-SES Population of Normal Weight and Overweight/Obese Children With Asthma. 61
30619785 2018
33
Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials. 61
28734858 2017
34
The Differences in Serum Quantitative Specific IgE Levels Induced by Dermatophagoides pteronyssinus, Dermatophagoides farinae and Blomia tropicalis Sensitization in Intermittent and Persistent Allergic Asthma. 61
29348379 2017
35
The Role of Oxidative Stress in the Clinical Manifestations of Childhood Asthma. 61
28481134 2017
36
Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis. 61
28810625 2017
37
Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals' perceptions of asthma control with validated ACT scores. 61
28801654 2017
38
Risk factors hindering asthma symptom control in Saudi children and adolescents. 61
28218986 2017
39
Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study. 61
27886391 2017
40
Factors associated with childhood asthma control in a resource-poor center. 61
29302522 2017
41
Association Between Migraine and Atopic Diseases in Childhood: A Potential Protective Role of Anti-Allergic Drugs. 61
28160287 2017
42
Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. 61
28270216 2017
43
[Socioeconomic Costs of Asthma in the European Union, United States and Canada: A Systematic Review]. 61
28278149 2017
44
House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. 61
27471838 2017
45
Asthma Severity and the Controller Prescription in Children at 12 Tertiary Hospitals. 61
27826962 2017
46
Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. 61
27912982 2017
47
Epidemiology, triggers, and severity of childhood asthma in Ilesa, Nigeria: Implications for management and control. 61
29238123 2017
48
Exposure to secondhand smoke and asthma severity among children in Connecticut. 61
28362801 2017
49
Prevalence and determinants of asthma in adults in Kinshasa. 61
28464036 2017
50
[Quality of life and associated factors in asthma in a Primary Care Center. Application of the reduced version of the Asthma Quality of Life Questionnaire]. 61
26858229 2016
51
The asthma-anxiety connection. 61
27817815 2016
52
Protein profiles of CCL5, HPGDS, and NPSR1 in plasma reveal association with childhood asthma. 61
27145233 2016
53
Co-morbidities and cognitive status in a cohort of teenagers with asthma. 61
27177276 2016
54
Asthma control and need for future asthma controller therapy among inner-city Hispanic asthmatic children engaged in a pediatric asthma disease management program (the Breathmobile program, Mobile Asthma Care for Kids Network). 61
27221537 2016
55
Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma. 61
26971688 2016
56
Parent and child asthma illness representations: a systematic review. 61
26785738 2016
57
Preventing Exacerbations in Preschoolers With Recurrent Wheeze: A Meta-analysis. 61
27230765 2016
58
Multum non multa: airway distensibility by forced oscillations. 61
27374218 2016
59
Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. 61
25716136 2016
60
Epidemiology of bronchial asthma in school children (10-16 years) in Srinagar. 61
27051105 2016
61
Effects of Traditional Chinese Medicine herbs for tonifying Qi and kidney, and replenishing spleen on intermittent asthma in children aged 2 to 5 years old. 61
26946616 2016
62
Impulse Oscillometry as a Predictor of Asthma Exacerbations in Young Children. 61
26756585 2016
63
Postural stability in school-age children with mild bronchial asthma disease (a pilot study). 61
26291139 2016
64
Diagnostic Value of Serum Baseline Tryptase Levels in Childhood Asthma and Its Correlation with Disease Severity. 61
28049209 2016
65
A 46-Year-Old Woman With Dyspnea From an Inhalational Exposure, Triggering Thyroid Storm and Subsequent Multi-Organ System Failure. 61
25680979 2015
66
Asthma deaths in children in New South Wales 2004-2013: Could we have done more? 61
26135337 2015
67
Prescription patterns of inhaled corticosteroids for preschool children--A Norwegian register study. 61
26110251 2015
68
A 44-year-old man with bilateral pneumothorax. 61
26437819 2015
69
The Effect of Viola odorata Flower Syrup on the Cough of Children With Asthma: A Double-Blind, Randomized Controlled Trial. 61
25954025 2015
70
Nutritional status, adiposity and asthma severity and control in children. 61
25872953 2015
71
Sublingual immunotherapy for asthma. 61
26315994 2015
72
Asthma history, job type and job changes among US nurses. 61
25713153 2015
73
Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. 61
25908767 2015
74
Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma. 61
25840484 2015
75
SERUM YKL-40 IN CHILDREN WITH ASTHMA. 61
26634596 2015
76
Caregiving burden and uplifts: a contradiction or a protective partnership for the quality of life of parents and their children with asthma? 61
25730405 2015
77
Decline in asthma prevalence and severity in Israel over a 10-year period. 61
25471899 2015
78
Association between dietary habits and asthma severity in children. 61
25638180 2015
79
A 33-month-old with fever and altered mental status. 61
25489012 2015
80
Lactic acidosis and diastolic hypotension after intermittent albuterol nebulization in a pediatric patient. 61
26744665 2015
81
Handgrip strength test as a complementary tool in monitoring asthma in daily clinical practice in children. 61
25148798 2014
82
Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma. 61
25515668 2014
83
Mismatch between asthma symptoms and spirometry: implications for managing asthma in children. 61
25175496 2014
84
Platelet aggregation, secretion, and coagulation changes in children with asthma. 61
24842314 2014
85
Effects of pollen season on central and peripheral nitric oxide production in subjects with pollen asthma. 61
25052059 2014
86
Sensitivity to Five Types of House Dust Mite in a Group of Allergic Egyptian Children. 61
25276487 2014
87
Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city. 61
25000942 2014
88
Evaluation of airway wall thickness via high-resolution computed tomography in mild intermittent asthma. 61
24106318 2014
89
Asthma exacerbation in children: a practical review. 61
24211086 2014
90
Risk factors affecting quality of life in a group of Italian children with asthma. 61
25004835 2014
91
The relationship of aeroallergen sensitization phenotypes to asthma control in primarily Hispanic asthmatic children. 61
24256059 2014
92
[Childhood asthma: Danish guidelines for diagnosis and treatment]. 61
23937873 2013
93
The role of transforming growth factor-β1 in airway inflammation of childhood asthma. 61
24067469 2013
94
Trend in asthma severity in steroid naive asthmatic children in Benin city, Nigeria. 61
23771464 2013
95
Quality of life of asthmatic children and adolescents: relation to maternal coping. 61
23828049 2013
96
A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. 61
23621498 2013
97
No direct association among respiratory function, disease control and family functioning in a sample of Mexican children with intermittent asthma. 61
23754351 2013
98
Passive smoking induces leukotriene production in children: influence of asthma. 61
23398266 2013
99
Use of impulse oscillometry system in assessment of asthma severity for preschool children. 61
23294170 2013
100
Bariatric surgery: severity, level of control, and time required for preoperative asthma control. 61
23015269 2013
101
[Exacerbations of asthma in Guadeloupe (French West Indies) and volcanic eruption in Montserrat (70 km from Guadeloupe)]. 61
23497930 2013
102
Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. 61
23333113 2013
103
Higher Environmental Relative Moldiness Index (ERMI) values measured in homes of asthmatic children in Boston, Kansas City, and San Diego. 61
23137280 2013
104
A case of mite-ingestion-associated exercise- induced anaphylaxis mimicking wheat-dependent exercise-induced anaphylaxis. 61
23921625 2013
105
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. 61
23144325 2013
106
The complex link between severity of asthma and rhinitis in mite allergic patients. 61
23146556 2013
107
Expression of resistin, CXCR3, IP-10, CCR5 and MIP-1α in obese patients with different severity of asthma. 61
23760409 2013
108
Fraction of exhaled nitric oxide and bronchial responsiveness are associated and continuous traits in young children independent of asthma. 61
23187857 2012
109
Asthma self-management: a study in an emergency room of a chest hospital in delhi, India. 61
23532570 2012
110
Positive exercise test and obstructive spirometry in young male conscripts associated with persistent asthma 20 years later. 61
23106120 2012
111
GSTM1 and GSTP1 gene variants and the effect of air pollutants on lung function measures in South African children. 61
22228263 2012
112
Haplotypic association of ADAM33 (T+1, S+1 and V - 3) gene variants in genetic susceptibility to asthma in Indian population. 61
22989201 2012
113
In athletes with mild intermittent asthma, is a beta-2 agonist 15-30 minutes prior to activity more effective at preventing an asthma attack than a daily inhaled steroid? 61
23304899 2012
114
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of Italian general practitioners. 61
22957769 2012
115
High physician adherence to phenotype-specific asthma guidelines, but large variability in phenotype assessment in children. 61
22834900 2012
116
Pollen starch granules in bronchial inflammation. 61
22920077 2012
117
Bronchial and alveolar nitric oxide in exercise-induced bronchoconstriction in asthmatic children. 61
22805466 2012
118
Children and adolescents with mild intermittent or mild persistent asthma: aerobic capacity between attacks. 61
22964927 2012
119
Improving parental adherence with asthma treatment guidelines: a randomized controlled trial of an interactive website. 61
22694878 2012
120
Exhaled breath condensate MMP-9 level and its relationship wıth asthma severity and interleukin-4/10 levels in children. 61
22541398 2012
121
Urinary leukotriene excretion profile in children with exercise-induced asthma compared with controls: a preliminary study. 61
21703750 2012
122
The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. 61
22374197 2012
123
[Knowledge, attitudes and practices of general practitioners about asthma in the city of Ouagadougou]. 61
22947245 2012
124
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. 61
22545149 2012
125
Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. 61
22125781 2011
126
Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens. 61
22360134 2011
127
Analysis of physiological variables during acute hypoxia and maximal stress test in adolescents clinically diagnosed with mild intermittent or mild persistent asthma. 61
22241027 2011
128
Management of plastic bronchitis in a child with mild intermittent asthma. 61
22224309 2011
129
Perception of dyspnea in prepubescent children with mild intermittent asthma: is there any gender difference? 61
21913878 2011
130
Effectiveness of Ischia thermal water nasal aerosol in children with seasonal allergic rhinitis: a randomized and controlled study. 61
22230419 2011
131
Improving paediatric asthma outcomes in primary health care: a randomised controlled trial. 61
21978349 2011
132
Ethnic variability in persistent asthma after in utero tobacco exposure. 61
21859918 2011
133
Asthma prescription patterns for children: can GPs do better? 61
21190392 2011
134
Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. 61
21071468 2011
135
Varicella zoster vasculopathy. 61
21430239 2011
136
Prevalence and severity of asthma in obese adult candidates for bariatric surgery. 61
21755187 2011
137
Factors associated with asthma severity in children: a case-control study. 61
21332431 2011
138
House dust mite sublingual immunotherapy: results of a US trial. 61
21333346 2011
139
The increase in exhaled NO following allergen challenge is not associated with airway acidification. 61
21114492 2011
140
Improving asthma care in emergency departments: results of a multihospital collaborative quality initiative in rural western North Carolina. 61
21721495 2011
141
Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands. 61
21216083 2011
142
Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK. 61
20936252 2011
143
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 61
21121983 2011
144
Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study. 61
21899211 2011
145
Actual control state of intermittent asthma classified on the basis of subjective symptoms. 61
21804279 2011
146
Early interventions with inhaled corticosteroids in asthma: benefits and risks. 61
21116135 2011
147
Montelukast: more than a cysteinyl leukotriene receptor antagonist? 61
21170491 2010
148
Current situation of asthma therapy by allergists in primary medical facilities in Japan. 61
20864794 2010
149
Maximal degree of airway narrowing induced by methacholine and adenosine monophosphate: relationship with the decrease in forced vital capacity. 61
21130378 2010
150
Sublingual immunotherapy for Alternaria-induced allergic rhinitis: a randomized placebo-controlled trial. 61
21055665 2010
151
Short-term effects of air pollution on wheeze in asthmatic children in Fresno, California. 61
20570778 2010
152
Characterization of the asthmatic population of St. Vincent and the Grenadines: asthma severity levels and atopic sensitization. 61
20846086 2010
153
Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases. 61
21244770 2010
154
The Breathmobile program: a good investment for underserved children with asthma. 61
20934626 2010
155
Asthma: specific clinical and functional characteristics in childhood. Results of a national program in Romanian asthmatic children. 61
21192627 2010
156
Distribution of severity of asthma in childhood. 61
20938593 2010
157
Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. 61
21416785 2010
158
The clinical efficacy of a sublingual monomeric allergoid at different maintenance doses: a randomized controlled trial. 61
20943066 2010
159
Total control of asthma: an evaluation in patients of a tertiary hospital. 61
21255524 2010
160
Exhaled carbon monoxide in asthmatics: a meta-analysis. 61
20433745 2010
161
Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. 61
20527510 2010
162
Effect of pregnancy on maternal asthma symptoms and medication use. 61
20177287 2010
163
[Impact of inhaled corticosteroid prescription at discharge from the emergency room on exacerbations of asthma in Japanese hospital]. 61
20212354 2010
164
Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings. 61
19921960 2010
165
Asthma severity according to Global Initiative for Asthma and its determinants: an international study. 61
19672098 2010
166
Anesthesia for partial bilateral salpingectomy in a patient with idiopathic hypertrophic cardiomyopathy: case report and review of the literature. 61
20169264 2010
167
Paediatric asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study. 61
20122626 2009
168
Inhaled corticosteroids should be initiated before discharge from the emergency department in patients with persistent asthma. 61
19995133 2009
169
Six-year follow-up of an intervention to improve the management of preschool children with asthma. 61
19689480 2009
170
Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. 61
19920048 2009
171
[Economic cost of treating the patient with asthma in Spain: the AsmaCost study]. 61
19525051 2009
172
Relationship between bronchial hyperreactivity and asthma remission during adolescence. 61
19788016 2009
173
Effects of pets on asthma development up to 8 years of age: the PIAMA study. 61
19245426 2009
174
T cells and eosinophils in bronchial smooth muscle cell death in asthma. 61
19400895 2009
175
Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. 61
19449366 2009
176
High prevalence of depression amongst mothers of children with asthma. 61
19484675 2009
177
Severity of asthma: the role of CD25+, CD30+, NF-kappaB, and apoptotic markers. 61
19610265 2009
178
Treatment strategies in mild asthma. 61
19093316 2009
179
[Relationship between airway basement membrane thickness and lung function tests in patients with asthma]. 61
19591096 2009
180
Association between skin testing in the pediatric emergency department and adherence to follow-up in children with asthma. 61
19205283 2009
181
[Administration of budesonide (inhaled steroid) to children to control intermittent asthma]. 61
19374158 2009
182
Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. 61
19087256 2008
183
Universal influenza vaccination and live attenuated influenza vaccination of children. 61
18820568 2008
184
Evaluation of the asthma control questionnaire validated for use in Brazil. 61
19009207 2008
185
Bronchospasm after intravenous lidocaine. 61
18806038 2008
186
Physician perspectives regarding annual influenza vaccination among children with asthma. 61
18922502 2008
187
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. 61
18727478 2008
188
National study of asthma quality of life--application of the Asthma Quality of Life Questionnaire (AQLQ-M) by Marks in the Portuguese population. 61
18622525 2008
189
Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma. 61
18430318 2008
190
Epithelium expression and function of retinoid receptors in asthma. 61
17884991 2008
191
The relationship between school absence, academic performance, and asthma status. 61
18307609 2008
192
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. 61
18061653 2008
193
Influence of atopy on asthma severity in adult female patients. 61
18361100 2008
194
The effects of inhaled corticosteroids on intrinsic responsiveness and histology of airways from infant monkeys exposed to house dust mite allergen and ozone. 61
17991502 2008
195
[Depression, anxiety and quality of life in pediatric asthma]. 61
18055395 2007
196
Exhaled breath condensate pH and hydrogen peroxide as non-invasive markers for asthma. 61
18060217 2007
197
Outcome and severity of adult onset asthma--report from the obstructive lung disease in northern Sweden studies (OLIN). 61
17689949 2007
198
[Relationship between body mass index and asthma severity in adults]. 61
18200363 2007
199
Does current asthma control predict future health care use among black preschool-aged inner-city children? 61
17974713 2007
200
Long-term asthma therapy: adapt steroid therapy to severity. 61
17926841 2007
201
An unusual presentation of adenoid cystic carcinoma of the minor salivary glands with cranial nerve palsy: a case study. 61
17697321 2007
202
The natural history of asthma from childhood to adulthood. 61
17627712 2007
203
[Relation between asthma severity and body mass index. Case series]. 61
18297849 2007
204
Is there any point in a corticosteroid treatment of intermittent asthma? 61
17619791 2007
205
The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. 61
17346807 2007
206
The impact of bronchiectasis in clinical presentation of asthma. 61
17534081 2007
207
Metabolomics applied to exhaled breath condensate in childhood asthma. 61
17303796 2007
208
What can predict the exacerbation severity in asthma? 61
17619565 2007
209
Management approaches to intermittent wheezing in young children. 61
17351473 2007
210
Severe intermittent wheezing in preschool children: a distinct phenotype. 61
17336610 2007
211
Short-course montelukast for intermittent asthma in children: a randomized controlled trial. 61
17110643 2007
212
Effect of formaldehyde on asthmatic response to inhaled allergen challenge. 61
17384766 2007
213
Role of IL-13 in the pathogenesis of bronchial asthma. 61
20306654 2007
214
Psychogenic cough in an asthmatic child: case report with unusual findings. 61
17365198 2007
215
Comparison between the drug treatment used in children up to five years of age treated in an emergency room and the guidelines established in the III Brazilian Consensus on Asthma Management. 61
17568862 2007
216
Correlation between asthma severity and serum IgE in asthmatic children sensitized to Dermatophagoides pteronyssinus. 61
17174732 2007
217
Occupational asthma: what can be done to prevent it? 61
20476951 2007
218
History of serious asthma exacerbations should be included in guidelines of asthma severity. 61
17141850 2007
219
Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. 61
17088131 2006
220
[Validation study of the Spanish adaptation of the satisfaction with inhaled asthma treatment questionnaire]. 61
17125692 2006
221
Buffering airway acid decreases exhaled nitric oxide in asthma. 61
17030232 2006
222
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. 61
17012630 2006
223
Use of the health plan employer data and information set for measuring and improving the quality of asthma care. 61
17042134 2006
224
Cough frequency in children with mild asthma correlates with sputum neutrophil count. 61
16670174 2006
225
Asthma management in a public referral center in Porto Alegre in comparison with the guidelines established in the III Brazilian Consensus on Asthma Management. 61
17268740 2006
226
The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma. 61
16918513 2006
227
Classification of asthma severity in children: the contribution of pulmonary function testing. 61
16894085 2006
228
Functional assessment of allergic asthmatic children while asymptomatic. 61
16948350 2006
229
Prognostic factors of asthma severity: a 9-year international prospective cohort study. 61
16750983 2006
230
Delivering tailored asthma family education in a pediatric emergency department setting: a pilot study. 61
16777829 2006
231
Asthma care and management before an emergency department visit in children in western Michigan: how well does care adhere to guidelines? 61
16777827 2006
232
National Asthma Education and Prevention Program severity classification as a measure of disease burden in children with acute asthma. 61
16777834 2006
233
Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma? 61
16046260 2006
234
Asthma-related resource use and cost by GINA classification of severity in three European countries. 61
16338597 2006
235
Variant in promoter region of platelet-derived growth factor receptor-alpha (PDGFRalpha) gene is associated with the severity and allergic status of childhood asthma. 61
16804324 2006
236
Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. 61
16292777 2006
237
3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. 61
16364162 2006
238
Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions. 61
16291080 2005
239
[Compliance with and acceptability of a new electronic peak flow meter, the PiKo-1]. 61
16160678 2005
240
Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community-based study in Hong Kong and Guangzhou. 61
16297141 2005
241
Medical charge of asthma care in admitted Thai children. 61
16856420 2005
242
Pharmacotherapy--treatment of intermittent asthma with ICSs. 61
16157734 2005
243
Impact of disease severity on quality of life in adults with asthma. 61
16091873 2005
244
[Characteristics of Mexican asthmatic subjects attending an outpatient service]. 61
16315635 2005
245
Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. 61
15940127 2005
246
Current treatment options for asthma in adults. 61
16210996 2005
247
Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma. 61
15966131 2005
248
Quality of life and polysensitization in young men with intermittent asthma. 61
15984595 2005
249
[Cost and management of asthma attacks treated in primary care (COAX Study)]. 61
15946608 2005
250
Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. 61
15832052 2005
251
Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis. 61
15853953 2005
252
Underestimation of the peak flow variability in asthmatic children: evaluation of a new formula. 61
15704185 2005
253
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. 61
15542792 2005
254
[The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma]. 61
17877115 2005
255
Adult asthma severity in individuals with a history of childhood asthma. 61
15637548 2005
256
[Bronchial provocation tests using methacholine, cycle ergometer exercise and free running in children with intermittent asthma]. 61
15742089 2005
257
Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. 61
15461603 2004
258
Bronchial reactivity in hyperresponsive patients and healthy individuals: demonstration with high resolution computed tomography. 61
15489072 2004
259
Fractional exhaled nitric oxide (FENO), lung function and airway hyperresponsiveness in naïve atopic asthmatic children. 61
15584636 2004
260
Quality of life in pediatric patients with asthma with or without obesity: a pilot study. 61
15456621 2004
261
Predictive value of a cross-cultural asthma case-detection tool in an elementary school population. 61
15342891 2004
262
Characteristics of children with asthma who are enrolled in a Head Start program. 61
15356547 2004
263
Survey of asthma control in Thailand. 61
15363011 2004
264
Steroids and antibiotics for treatment of acute asthma exacerbations in African-American children. 61
15253326 2004
265
Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. 61
15087294 2004
266
Clinical implications of airway inflammation in mild intermittent asthma. 61
15237759 2004
267
[Asthma treatment in childhood: from guidelines to practice]. 61
15301807 2004
268
Changes in body water distribution during treatment with inhaled steroid in pre-school children. 61
15204348 2004
269
Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma. 61
15028562 2004
270
Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. 61
15144472 2004
271
Long-term deterioration of lung function in asthmatic outpatients. 61
15133342 2004
272
Mild persistent asthma. Traits, treatment set it apart from mild intermittent asthma. 61
15171077 2004
273
Asthma among homeless children: undercounting and undertreating the underserved. 61
14993083 2004
274
Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs. 61
15049395 2004
275
Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism. 61
15061398 2004
276
How frequent are asthma exacerbations in a pediatric primary care setting and do written asthma action plans help in their management? 61
15641630 2004
277
The wheezy infant -- immunological and molecular considerations. 61
14980249 2004
278
Asthma in Wisconsin adults: a persistent problem for patients and providers. 61
15217121 2004
279
Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites. 61
14675476 2003
280
Gender differences in health-related quality of life among patients with asthma. 61
14736095 2003
281
[Fixed combinations as a first line treatment for all degrees of severity in asthma?]. 61
14618512 2003
282
Specific immunotherapy [correction of immunotheraphy] of allergic diseases: a three years perspective observational study. 61
14611732 2003
283
A longitudinal study of adult-onset asthma incidence among HMO members. 61
12952547 2003
284
Improvement of clinical and immunopathologic parameters in asthmatic children treated for concomitant chronic rhinosinusitis. 61
12877453 2003
285
Exercise-induced bronchospasm in children: comparison of FEV1 and FEF25-75% responses. 61
12772223 2003
286
Clinical and biological heterogeneity in children with moderate asthma. 61
12574073 2003
287
Measurement of nasal potential difference in mild asthmatics. 61
12740262 2003
288
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 61
12915743 2003
289
Steroid-naive adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and elevated exhaled nitric oxide levels. 61
12807174 2003
290
Airway structural alterations selectively associated with severe asthma. 61
12531777 2003
291
Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response. 61
12684247 2003
292
[Asthma and scuba diving]. 61
15095697 2003
293
Tolerance to the protective effect of salmeterol in mild untreated asthmatics. 61
14580927 2003
294
Antiasthmatic effects of nedocromil sodium. 61
15168867 2003
295
Treatment of allergic asthma. 61
12517577 2002
296
Increased leukotrienes in exhaled breath condensate in childhood asthma. 61
12406853 2002
297
Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. 61
12403689 2002
298
The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. 61
12379546 2002
299
Peanut allergy: an increasing health risk for children. 61
12424985 2002
300
Immunotherapy for allergic asthma. 61
12432871 2002
301
Vitamin A status in children with asthma. 61
12144646 2002
302
Mild intermittent asthma: CT assessment of bronchial cross-sectional area and lung attenuation at controlled lung volume. 61
11930065 2002
303
Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines. 61
11926628 2002
304
The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. 61
11834641 2002
305
Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. 61
12109533 2002
306
Patient self-management of acute asthma: adherence to national guidelines a decade later. 61
11731656 2001
307
Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma. 61
11641510 2001
308
Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. 61
11714077 2001
309
Magnesium concentration in plasma, leukocytes and urine of children with intermittent asthma. 61
11580927 2001
310
Exhaled nitric oxide and asthma in young children. 61
11568992 2001
311
Quantification of the effect of inhaled budesonide on airway inflammation in intermittent asthma by bronchitis index. 61
11714082 2001
312
Children with asthma and nebulizer use: parental asthma self-care practices and beliefs. 61
11714079 2001
313
Impact of a targeted asthma intervention program on treatment costs in patients with asthma. 61
11570023 2001
314
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. 61
11591189 2001
315
Diagnosing pediatric asthma: validating the Easy Breathing Survey. 61
11487755 2001
316
Asthma symptoms, morbidity, and antiinflammatory use in inner-city children. 61
11483788 2001
317
Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma. 61
11338289 2001
318
[Epidemiological, clinical and progressive aspects of asthma observed at Bamako, Mali]. 61
11440885 2001
319
Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. 61
11284796 2001
320
Airway inflammation and remodeling in asthma : current concepts. 61
21336887 2001
321
Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. 61
11083702 2000
322
[Utilization of anti-asthmatic drugs among Danish children in 1998]. 61
11107942 2000
323
Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. 61
11029371 2000
324
Exercise, methacholine, and adenosine 5'-monophosphate challenges in children with asthma: relation to severity of the disease. 61
10973039 2000
325
Role of leukotriene receptor antagonists in pediatric asthma. 61
10922143 2000
326
Helicobacter pylori sero-prevalence in asthma. 61
10955750 2000
327
Safety of over-the-counter inhalers for asthma: report of the council on scientific affairs. 61
10936150 2000
328
Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. 61
10817797 2000
329
Guideline for the management of chronic asthma in adults--2000 update. South African Pulmonology Society Adult Asthma Working Group. 61
10901829 2000
330
[Degree of skin hypersensitivity as possible indicator of severity of asthma in the atopic subject]. 61
10887771 2000
331
Laryngospasm and paradoxical bronchoconstriction after repeated doses of beta 2-agonists containing edetate disodium. 61
10725956 2000
332
Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. 61
10619834 2000
333
Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma. 61
10641740 1999
334
Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. 61
10550740 1999
335
Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. 61
10581661 1999
336
Increased progenitor cell proliferation in the peripheral blood of patients with bronchial asthma: the role of nitric oxide. 61
10518825 1999
337
Serum eosinophil cationic protein (sECP) in subjects with a history of asthma symptoms with or without rhinitis. 61
10505459 1999
338
Exercise-induced bronchospasm in children: effects of asthma severity. 61
10351925 1999
339
Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. 61
10371095 1999
340
Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. 61
10065675 1999
341
Effectively managing asthma in young and middle adulthood. 61
9950001 1999
342
Airway inflammation in mild intermittent and in persistent asthma. 61
9476850 1998
343
[A modern approach to the treatment of bronchial asthma]. 61
8925549 1996
344
Inhaled platelet-activating factor worsens gas exchange in mild asthma. 61
8049817 1994
345
Persistent wheezing and gastroesophageal reflux in infants. 61
7970907 1994
346
National guidelines for the management of asthma in adults. 61
1357947 1992
347
Vocal cord dysfunction in a child with asthma. 61
2013561 1991
348
The effects of nalmefene, a potent oral opiate antagonist, on exercise-induced bronchospasm. 61
3204249 1988
349
The effect of oral diltiazem on airway reactivity to methacholine and exercise in subjects with mild intermittent asthma. 61
3314613 1987
350
Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge. 61
3533454 1986
351
Current concepts in clinical therapeutics: asthma. 61
2869853 1986
352
[Growth and chronic bronchopneumopathies]. 61
3915544 1985
353
The natural history of asthma: aeromedical implications. 61
6732700 1984
354
RAPID THERAPY WITH BETAMETHASONE IN SEVERE INTERMITTENT ASTHMA. 61
14199877 1964

Variations for Intermittent Asthma

Expression for Intermittent Asthma

Search GEO for disease gene expression data for Intermittent Asthma.

Pathways for Intermittent Asthma

GO Terms for Intermittent Asthma

Sources for Intermittent Asthma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....